| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |